Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Roche Launches the AVENIO Edge System to Simplify and Automate Next-generation Sequencing Sample Preparation, Reduce Human Error and Advance Precision Medicine
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the AVENIO Edge System, […]
Bloom Science Raises USD $12 Million in Series A Financing
San Diego based biotech company Bloom Science announced today it successfully closed a USD $12 Million Series A […]
Equine Sarcoids - Visible Success with DelNS-based Immunotherapy Leads the Way Towards Cancer Therapy in Humans
Scientists from the Viennese biotech company BlueSky Immunotherapies GmbH (Ltd.) have used their viral vector platform delNS […]
FDA Approves NGS-Based Companion Diagnostic for EGFR Exon20 Insertion Mutant Non-Small Cell Lung Cancer Tumor Tissue
The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific‘s Oncomine Dx Target […]
Vésale Bioscience Named Most Innovative Start-up in Life Sciences in Europe at Tenth Edition of BioFIT
Vésale Bioscience, a biotech company specializing in phage therapy, with a particular focus on research […]
Fujitsu and MIT's Center for Brains, Minds, and Machines Develop AI Technology Inspired by the Human Brain Able to Recognize Unseen Data with High Accuracy
Fujitsu Limited and the Center for Brains, Minds and Machines (CBMM) headquartered at the Massachusetts Institute […]
BICO and Nanochon Announce Commercial Agreement to Develop 3D Printed Joint Restoration Implant
Today BICO, the world’s leading bio convergence company, announced partnership with Nanochon, a startup developing regenerative joint replacements. Under […]
UK's Most Vulnerable People to Receive Life-saving COVID-19 Treatments in the Community
Thousands of the UK’s most vulnerable people will be among the first in the world to […]
Optibrium Shows Deep Learning to Successfully Predict Human Panel-based Sensory Perception of Novel Compounds Used for Flavours and Fragrances
Optibrium Limited, a leading provider of software and artificial intelligence (AI) solutions for drug discovery, […]
Evusheld (Formerly AZD7442) Long-acting Antibody Combination Authorised for Emergency Use in the US for Pre-exposure Prophylaxis (Prevention) of COVID-19
AstraZeneca‘s Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorisation (EUA) in the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more